Furthermore, Patel et al. studied MMP-2 and -9 as serum prognostic biomarkers in a cohort of 60 women with primary breast cancer, 40 with benign breast disease, and 60 healthy controls in India. This evidence concerns the gene MMP2 and breast cancer.